- Home
- INLF vs SNSE Comparison
INLF vs SNSE Comparison
Compare INLF & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INLF | SNSE |
|---|---|---|
| Founded | 2016 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 10.3M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | INLF | SNSE |
|---|---|---|
| Price | $0.51 | $9.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $72.50 |
| AVG Volume (30 Days) | ★ 562.6K | 84.7K |
| Earning Date | 09-29-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $19,332,282.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 33.11 | N/A |
| 52 Week Low | $0.48 | $5.00 |
| 52 Week High | $21.00 | $18.35 |
Technical Indicators
Market Signals| Indicator | INLF | SNSE |
|---|---|---|
| Relative Strength Index (RSI) | 29.61 | 51.50 |
| Support Level | $0.50 | $8.37 |
| Resistance Level | $0.54 | $9.60 |
| Average True Range (ATR) | 0.03 | 0.83 |
| MACD | -0.00 | 0.13 |
| Stochastic Oscillator | 17.17 | 41.18 |
Price Performance
Historical ComparisonAbout INLF INLIF LIMITED
INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).